Introduction
Propofol is an intravenously administered induction agent causing hypnosis. It is mainly used for induction and maintenance of general anaesthesia, sedation in critical care units in adults, mechanically ventilated patients and procedural sedation, total intravenous anaesthesia, anticonvulsant and as an antiemetic 1 .Propofol is the drug of choice for induction of anaesthesia in millions of patients every year because of its rapid onset and short duration of action, easy titration and favourable profile for side effects 1 . Although it decreases the incidences of nausea and vomiting 1 ,one of the disadvantages of propofol use for induction is the pain caused during injection 1, 2 .The pain occurs in 28%-90%of patients 3 .Some patients recall the induction of anaesthesia as the most painful part of the perioperative period 4 . Ye et al. 5 , demonstrated that ondansetron, a specific 5-hydroxytryptamine antagonist, blocks sodium channels in the rat brain neurons. They also found that ondansetron was 15 timesmore potent than lidocaine in causing numbness when injected under the skin . Ondansetron is a well-established agent for prevention of postoperative nausea and vomiting after surgical procedures.
Tramadol is a centrally acting weak μ-receptor agonist and inhibits nor-adrenaline re-uptake and promotes serotonin release. Wong andCheong reported that pre-treatment with tramadol was as effective as lidocaine in alleviating pain on propofol injection 6. However there is relatively very little published data on the efficacy of ondansetron on the pain on injection of propofol. In this study we evaluated the effectiveness of ondansetron and tramadol pre-treatment for alleviation of pain on propofol injection II.
Materials And Method
The study was an open label observer blind prospective randomized controlled study of 300 cases. Cases were divided into three groups of 100 each as per group sequential analysis. Group I: In this group, patients receivedintravenous ondansetron 4 mg in 2 ml normal saline before propofol injection. Group II: In this group, patients receivedintravenous tramadol 50 mg in 2 ml normal saline before propofol injection. Group III: In this group, patients received intravenous normal saline 2 ml before propofol injection.
The drugs were given to the patients by investigators according to random number table but the observers taking the readings were blind about the drug given. 
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Study method-
After institutional ethics committee approval the study was conducted in 300 patients of ASA I and II status and of age group 18-60years presenting for elective surgeries under general anaesthesia. Informed consent was taken. The patients were explained about the procedure during the pre-anaesthetic visit. Patients who had a history of allergic response to either propofol or 5HT receptor antagonist, or received any analgesic or sedative drugs within 24 hours prior to surgery, were excluded from this study. Patients received intravenously either ondansetron pre-treatment 4 mg in a total volume of 2 ml or tramadol pre-treatment 50mg in total volume 2ml or 2 ml 0.9% saline pre-treatment as a placebo 60 seconds before the administration of propofol according to a randomization list. All drugs were prepared at operating room temperature (21-23°C) by an anaesthesiologist. No patient was given any premedication or analgesic before the pre-treatment injection.
On arrival in the operation theatre, a 20G cannula was inserted into a vein on the dorsum of the patient's non-dominant hand and lactated Ringer's solution was infused. Heart rate and non-invasive blood pressure were measured. Heart rate, blood pressure and peripheral oxygen saturation were recorded before injecting propofol and at 1 and 3 min after. Each patient received 2 ml of the pre-treatment solution for a period of 5 seconds 5 min after i.v. cannulation (time taken for applying monitors) while the venous drainage was occluded manually at mid-arm by an assistant. One minute after intravenous injection of pre-treatment solution, the occlusion was released and anaesthesia was induced with propofol intravenously. The initial 2 ml bolus was given over 5 seconds and the patient was asked to rate immediately any sensation of pain during injection of propofol. Also the verbal response and behavioural response such as facial grimacing, arm withdrawal or tears were noted. The grading of pain was done. Evaluation of pain during injection of propofol was done using Mc Crirrick and Hunter scale 7 
III. Results
The study included 300 patients. The overall incidence of pain was 82.2% in the saline group, 13.3% in the tramadol group, and 24.4% inthe ondansetron group. Pain intensity was significantly less in patients receiving drugs for pre-treatment than those receiving saline (P=0.001). 4 mg ondansetron, like 50 mg tramadol, significantly reduced the incidence of propofol injection pain. The efficacy of ondansetron in alleviating the incidence and severity of propofol injection pain was no different from tramadol (P=0.330). No significant association was found between gender and pain (P=0.855). 
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IV. Discussion
Propofol is a commonly used intravenous induction agent. It possesses many characteristics of an ideal anaesthetic agent. The most common side effect is pain on injection. In this study we compared the efficacy of i.v. ondansetron and i.v. tramadol on i.v.propofol injection pain using i.v.saline as control.It was a prospective, randomised, double blind placebo controlled study conducted on 300 patients of ASA I& II status who were randomly assigned into three groups of 100 each as per group sequential analysis. Group I -Patients received i.v. ondansetron (4mg:2ml) Group II -Patients received i.v.tramadol(50mg:2ml) Group III -Patients received normal saline(2ml)
We found that wheni.v. ondansetron was used as the pre-treatment drug prior to propofol injection, 30% patients had mild, 16% moderate and 4% had severe pain.50% patients were painfree. On pretreatment with i.v. tramadol and subsequent propofol injection 86% patients were pain free.12% had mild pain,2% experienced moderate, none had severe pain.
On pre-treatment with normal saline and subsequent propofol injection 28% patients were pain free.54% patients had mild, 14% had moderate and 4% severe pain. Statistically significant increase in both mean pulse rate and mean arterial pressure from baseline was observed after subsequent propofol injection.
The overall incidence of pain was 82.2% in thesaline group, 13.3% in the tramadol group, and 24.4% inthe ondansetron group. Pain intensity was significantlyless in patients receiving drugs for pre-treatment thanthose receiving saline (P=0.001). 4 mg ondansetron, like 50 mg tramadol,significantly reduced the incidence of propofol injectionpain. The efficacy of ondansetron in alleviating theincidence and severity of propofol injection pain was nodifferent from tramadol (P=0.330).
V. Conclusion
Tramadol and ondansetron significantly reduced the incidence and severity of propofol injection pain more than placebo. The efficacy of ondansetron in alleviating the pain on injection propofol was no different from tramadol.Ondansetron pre-treatment may be used to reduce the incidence of pain on injection of propofol, an advantage added to the useful prevention of postoperative nausea and vomiting.
There is no significant difference between the effectiveness of ondansetron and tramadol in decreasing the pain on injection of propofol. In conclusion, ondansetron pretreatment provides a simple and safe method of reducing propofol injection pain with the advantage of preventing postoperative nausea and vomiting (PONV) and avoiding the administration of other drugs that may be undesirable in certain circumstances.
